{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:36:27Z","timestamp":1790681787988,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.radonc.2025.111009","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T19:50:21Z","timestamp":1750967421000},"page":"111009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Lymphocyte nadir and recovery dynamics for locally advanced thoracic malignancies undergoing concurrent chemo-irradiation: Establishment of organs-at-risk constraints"],"prefix":"10.1016","volume":"210","author":[{"given":"Ben Man Fei","family":"Cheung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6914-6890","authenticated-orcid":false,"given":"Kwok Keung","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai Yee","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis Kwok Chuen","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Ming Spring","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Ho-Fun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.111009_b0005","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer","volume":"384","author":"Kelly","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.radonc.2025.111009_b0010","unstructured":"Durvalumab after Chemoradiotherapy in Stage III Non\u2013Small-Cell Lung Cancer | New England Journal of Medicine. <https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1709937> [accessed March 13, 2025]."},{"key":"10.1016\/j.radonc.2025.111009_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1096386","article-title":"Effect of intensity modulated radiotherapy on lymphocytes in patients with esophageal squamous cell carcinoma and its clinical significance","volume":"13","author":"Tian","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.radonc.2025.111009_b0020","doi-asserted-by":"crossref","unstructured":"van Rossum PSN, Juan-Cruz C, Stam B, et al. Frontiers | Severe radiation-induced lymphopenia during concurrent chemoradiotherapy for stage III non-small cell lung cancer: external validation of two prediction models. doi:10.3389\/fonc.2023.1278723.","DOI":"10.3389\/fonc.2023.1278723"},{"key":"10.1016\/j.radonc.2025.111009_b0025","unstructured":"Abravan A, Faivre-Finn C, Kennedy J, McWilliam A, Herk M van. Radiotherapy-Related Lymphopenia Affects Overall Survival in Patients With Lung Cancer. <https:\/\/www.jto.org\/article\/S1556-0864(20)30478-0\/fulltext> [accessed February 26]."},{"key":"10.1016\/j.radonc.2025.111009_b0030","unstructured":"C X, Jy J, M Z, et al. The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy. PubMed. <https:\/\/pubmed.ncbi.nlm.nih.gov\/32182504\/> [accessed February 26, 2025]."},{"key":"10.1016\/j.radonc.2025.111009_b0035","unstructured":"Friedes C, Iocolano M, Lee SH, et al. The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC. <https:\/\/www.thegreenjournal.com\/article\/S0167-8140(23)09337-4\/abstract> [accessed February 26, 2025]."},{"key":"10.1016\/j.radonc.2025.111009_b0040","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13014-023-02354-w","article-title":"Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organs","volume":"18","author":"Tseng","year":"2023","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.radonc.2025.111009_b0045","unstructured":"W J, T X, L W, et al. Severe radiation-induced lymphopenia attenuates the benefit of durvalumab after concurrent chemoradiotherapy for NSCLC. PubMed. Published online 2022. <https:\/\/pubmed.ncbi.nlm.nih.gov\/36089921\/> [accessed February 26, 2025]."},{"key":"10.1016\/j.radonc.2025.111009_b0050","unstructured":"Y C, Y K, I C, et al. Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy. PubMed. <https:\/\/pubmed.ncbi.nlm.nih.gov\/35033601\/> [accessed February 26, 2025]."},{"key":"10.1016\/j.radonc.2025.111009_b0055","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.3390\/cancers13246193","article-title":"Higher radiation dose to the immune cells correlates with worse tumor control and overall survival in patients with stage III NSCLC: a secondary analysis of RTOG0617","volume":"13","author":"Jin","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2025.111009_b0060","unstructured":"Mauch P, Constine L, Greenberger J, et al. Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy. <https:\/\/www.redjournal.org\/article\/0360-3016(94)00430-S\/abstract> [accessed March 9, 2025]."},{"key":"10.1016\/j.radonc.2025.111009_b0065","doi-asserted-by":"crossref","DOI":"10.1148\/ryai.230024","article-title":"TotalSegmentator: robust segmentation of 104 anatomical structures in CT images","volume":"5","author":"Wasserthal","year":"2023","journal-title":"Radiol. Artif. Intell."},{"key":"10.1016\/j.radonc.2025.111009_b0070","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ijrobp.2009.11.040","article-title":"Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging","volume":"79","author":"Hayman","year":"2011","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"10.1016\/j.radonc.2025.111009_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1201500","article-title":"A review on lymphocyte radiosensitivity and its impact on radiotherapy","volume":"13","author":"Paganetti","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.radonc.2025.111009_b0080","unstructured":"M W, J H, Bg N, H B, Se B. Lymphopenia and risk of infection and infection-related death in 98,344 individuals from a prospective Danish population-based study. PubMed. Published online 2018. <https:\/\/pubmed.ncbi.nlm.nih.gov\/30383787\/> [accessed March 9, 2025]."},{"key":"10.1016\/j.radonc.2025.111009_b0085","unstructured":"Tang C, Liao Z, Gomez D, et al. Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes. <https:\/\/www.redjournal.org\/article\/S0360-3016(14)00496-9\/abstract> [accessed February 26, 2025]."},{"key":"10.1016\/j.radonc.2025.111009_b0090","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.adro.2020.03.021","article-title":"Lymphopenia and radiation dose to circulating lymphocytes with neoadjuvant chemoradiation in esophageal squamous cell carcinoma","volume":"5","author":"So","year":"2020","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.radonc.2025.111009_b0095","unstructured":"Deng W, Xu C, Liu A, et al. The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy. <https:\/\/www.thegreenjournal.com\/article\/S0167-8140(18)33623-5\/abstract> [accessed February 26, 2025]."},{"key":"10.1016\/j.radonc.2025.111009_b0100","doi-asserted-by":"crossref","unstructured":"Kang BH, Li X, Son J, et al. Frontiers | prediction and clinical impact of delayed lymphopenia after chemoradiotherapy in locally advanced non-small cell lung cancer. doi:10.3389\/fonc.2022.891221.","DOI":"10.3389\/fonc.2022.891221"},{"key":"10.1016\/j.radonc.2025.111009_b0105","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.ijrobp.2009.06.091","article-title":"Radiation dose volume effects in the lung","volume":"76","author":"Marks","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.111009_b0110","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13014-017-0824-x","article-title":"Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma","volume":"12","author":"Liu","year":"2017","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.radonc.2025.111009_b0115","article-title":"Assessing the spleen as an organ at risk in radiation therapy and its relationship with radiation-induced lymphopenia: a retrospective study and literature review","volume":"6","author":"Alexandru","year":"2021","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.radonc.2025.111009_b0120","unstructured":"Mell LK, Schomas DA, Salama JK, et al. Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. <https:\/\/www.redjournal.org\/article\/S0360-3016(07)04202-2\/fulltext> [accessed March 9, 2025]."},{"key":"10.1016\/j.radonc.2025.111009_b0125","unstructured":"Sm M, Sk B, W S, et al. Using [(18)F]fluorothymidine imaged with positron emission tomography to quantify and reduce hematologic toxicity due to chemoradiation therapy for pelvic cancer patients. PubMed. Published online 2016. <https:\/\/pubmed.ncbi.nlm.nih.gov\/27319286\/> [accessed March 9]."},{"key":"10.1016\/j.radonc.2025.111009_b0130","unstructured":"Nour CSD, Nour Y, Sahlmann J, et al. Impact of estimated dose of radiation to immune cells (EDRIC) in locally advanced Non-Small-Cell lung Cancer: A secondary analysis of the multicenter randomized PET-Plan trial. <https:\/\/www.thegreenjournal.com\/article\/S0167-8140(25)00202-6\/fulltext> [accessed April 28, 2025]."},{"key":"10.1016\/j.radonc.2025.111009_b0135","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.radonc.2020.12.019","article-title":"Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: a comparative analysis of proton versus photon therapy","volume":"156","author":"Kim","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2025.111009_b0140","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ijrobp.2023.08.058","article-title":"Severe lymphopenia during chemoradiation therapy for esophageal cancer: comprehensive analysis of randomized phase 2B trial of proton beam therapy versus intensity modulated radiation therapy","volume":"118","author":"Wang","year":"2024","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"10.1016\/j.radonc.2025.111009_b0145","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1748-717X-6-140","article-title":"Planning analysis for locally advanced lung cancer: dosimetric and efficiency comparisons between intensity-modulated radiotherapy (IMRT), single-arc\/partial-arc volumetric modulated arc therapy (SA\/PA-VMAT)","volume":"6","author":"Jiang","year":"2011","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.radonc.2025.111009_b0150","unstructured":"Yu Y, Fu P, Jin JY, et al. Impact of effective dose to immune cells (EDIC) on lymphocyte nadir and survival in limited-stage SCLC. <https:\/\/www.thegreenjournal.com\/article\/S0167-8140(21)06592-0\/abstract> [accessed April 28, 2025]."}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402504513X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402504513X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:26:02Z","timestamp":1789172762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402504513X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":30,"alternative-id":["S016781402504513X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111009","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphocyte nadir and recovery dynamics for locally advanced thoracic malignancies undergoing concurrent chemo-irradiation: Establishment of organs-at-risk constraints","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111009"}}